New drug E7386 tested in patients with advanced cancers
NCT ID NCT03833700
First seen Feb 28, 2026 · Last updated May 07, 2026 · Updated 7 times
Summary
This early-stage study tests a new drug called E7386 in people with advanced solid tumors, including colorectal cancer, who have no other treatment options. The main goal is to check the drug's safety and find the right dose. About 70 participants will take part, and the study is no longer recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eisai Trial Site #1
Chuo Ku, Tokyo, Japan
-
Eisai Trial Site #2
Kashiwa, Chiba, Japan
-
Eisai Trial Site #3
Nagaizumi-cho, Shizuoka, Japan
-
Eisai Trial Site #4
Fukuoka, Japan
-
Eisai Trial Site #5
Sapporo, Hokkaido, Japan
-
Eisai Trial Site#6
Osaka, Japan
-
Eisai Trial Site#7
Nagoya, Aichi-ken, Japan
-
Eisai Trial Site#8
Sendai, Miyagi, Japan
Conditions
Explore the condition pages connected to this study.